Upgrade to SI Premium - Free Trial

Alterity Therapeutics (ATHE)

3.90 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 6-K ALTERITY THERAPEUTICS For: Jun 30 June 3, 2026 6:05 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: May 31 May 29, 2026 6:08 AM - SEC Filing Alterity Therapeutics presents data supporting ATH434 Phase 3 advance in MSA May 19, 2026 7:25 AM - StreetInsider Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy May 19, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: May 31 May 19, 2026 6:06 AM - SEC Filing Form 424B3 Alterity Therapeutics May 12, 2026 3:40 PM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: May 31 May 12, 2026 6:07 AM - SEC Filing Alterity publishes study on MRI biomarker for multiple system atrophy May 11, 2026 7:25 AM - StreetInsider Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy May 11, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: May 31 May 11, 2026 6:04 AM - SEC Filing Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026 May 7, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: May 31 May 7, 2026 6:08 AM - SEC Filing Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update April 30, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 30, 2026 6:18 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 30, 2026 6:16 AM - SEC Filing Form 3 ALTERITY THERAPEUTICS For: Apr 17 Filed by: Cunningham Ann Michelle April 29, 2026 8:05 PM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 29, 2026 8:10 AM - SEC Filing Alterity Therapeutics receives FDA alignment on ATH434 manufacturing plans April 27, 2026 7:25 AM - StreetInsider Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy April 27, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 27, 2026 6:22 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 27, 2026 6:22 AM - SEC Filing Alterity Therapeutics shares new ATH434 trial data at neurology meeting April 22, 2026 7:25 AM - StreetInsider Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology April 22, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 22, 2026 6:07 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 21, 2026 6:05 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 20, 2026 6:59 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 20, 2026 6:57 AM - SEC Filing Alterity Therapeutics appoints Ann Cunningham to board of directors April 17, 2026 7:25 AM - StreetInsider Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors April 17, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 17, 2026 6:06 AM - SEC Filing Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting April 16, 2026 11:41 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 16, 2026 6:07 AM - SEC Filing Form 3 ALTERITY THERAPEUTICS For: Apr 15 Filed by: Stamler David Allen April 15, 2026 7:50 PM - SEC Filing Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy April 15, 2026 7:25 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 15, 2026 6:16 AM - SEC Filing Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Gozlan Lawrence Bernard April 10, 2026 8:22 AM - SEC Filing Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Babarczy Julian Michael April 10, 2026 8:17 AM - SEC Filing Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Marks Peter Ashley April 10, 2026 7:57 AM - SEC Filing Form 3 ALTERITY THERAPEUTICS For: Apr 09 Filed by: Macnish Niven Abby Sarah April 9, 2026 9:58 PM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Apr 30 April 1, 2026 6:11 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Mar 31 March 30, 2026 6:08 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Mar 31 March 26, 2026 11:27 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Mar 19 March 19, 2026 8:00 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Mar 13 March 16, 2026 6:02 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Mar 09 March 9, 2026 8:00 AM - SEC Filing Full Article List